Zacks Investment Research upgraded shares of EXACTECH INC (EXAC) from UNDERPERFORM to NEUTRAL on September 03, 2012, with a target price of $16.50.
Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech's orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on EXACTECH INC (EXAC),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment